Author:
de Sequera Patricia,Bover Ramón,Ivanova-Markova Yoana,Ivanova Alexandra,González-Domínguez Almudena,Valls Marta,Campos Verónica
Reference48 articles.
1. Expert consensus document on the management of hyperkalaemia in patients with cardiovascular disease treated with renin angiotensin aldosterone system inhibitors: coordinated by the Working Group on Cardiovascular Pharmacotherapy of the European Society of Cardiology
2. Consenso sobre el manejo de la hiperpotasemia en pacientes con insuficiencia cardíaca: recomendaciones de la SEC-SEMI;Almenar Bonet;Rev Clin Esp,2021
3. Informe de Posicionamiento Terapéutico de patiromer (Veltassa®) en el tratamiento de la hiperpotasemia. [Accessed 15 July 2019]. Available from: https://www.aemps.gob.es/medicamentosUsoHumano/informesPublicos/docs/IPT-patiromer-Veltassa-hiperpotasemia.pdf?x62011.
4. Hiperpotasemia crónica o persistente, una vieja entidad con nuevos protagonistas;Morales;Monogr Nefrol,2019
5. The clinical and economic burden of hyperkalemia on medicare and commercial payers;Fitch;Am Health Drug Benefits,2017